Given the pervasiveness of COVID-19 throughout the U.S., the risk of infection to transportation workers and passengers is significant. For instance, in a survey of over 600 bus and subway workers in New York City, almost one quarter reported contracting COVID-19, and 76 percent personally knew a coworker who had died from the disease. During last week’s hearing, […]
Comprehensive and reliable mortality data will enable more effective response to rapidly evolving public health challenges.
Environmental justice is a priority for the Biden administration, with the president advocating for the use of a whole-of-government approach based on the latest science to improve environmental conditions in low-income communities and communities of color. When pressed to expand on the administration’s vision during Wednesday’s Senate Environment and Public Works Committee hearing, Michael Regan, the president’s nominee […]
Increasing the share of health services provided directly to patient homes is a significant opportunity to improve healthcare in the U.S.
America’s leadership in space exploration could greatly accelerate through a fundamentally different approach to in-space operations.
An investment of $5 billion over five years will improve U.S. pharmaceutical manufacturing infrastructure.
A tax-and-dividend approach that mitigates the challenging impacts that carbon policies have on poor and suburban/rural communities.
The Federal Government should radically enhance its efforts to build community disaster resilience.
NASA should invest in a comprehensive Astrobiology Program Office to answer one of humanity’s biggest questions: “Are we alone?”
The government should provide incentives to healthcare providers that scale up and reduce costs of delivering preventive interventions.
The next administration should empower patients as partners in managing of their health data and tissue samples.
There has been a surge of public interest in the drug fluvoxamine as a potential treatment for individuals with mild COVID-19, and Congressional offices are receiving many questions about the possibility of using the drug to counter COVID-19 from constituents. This brief outlines what is known to date about fluvoxamine in the context of the […]